These organoids demonstrate both amyloid and tau pathologies, and more powerfully, this model shows a distinct time line: the increases in P-tau levels in these organoids occur later than the Aβ aggregates, similar to what occurs in the human FAD pathological process. This evidence concerns the gene MAPT and familial Alzheimer disease.